Pipeline

By working with established Active Pharmaceutical Ingredients (APIs), SST utilizes the FDA 505(b)(2) regulatory pathway to accelerate development and commercialization of both over-the-counter (OTC) and prescription drug product candidates. SST has three programs currently in active development. All formulas are patented.

Products

Topical Sildenafil – Prescription (Rx) Product for the Treatment of Female Sexual Arousal Disorder (FSAD)

Topical Sildenafil – Over the Counter (OTC) Product for the Treatment of Erectile Dysfunction (ED)

Topical Ibuprofen – Over the Counter (OTC) Product for the Treatment of Mild to Moderate Aches and Pains